Diabetes, Hyperglycemia
Conditions
Keywords
Glucose stimulated insulin secretion, copper, cytokines, diabetes, Reduction in insulin secretion
Brief summary
In the CDs rat model, beta-cell dysfunction and pancreatic exocrine damage are triggered and prevented by altering dietary Cu content suggesting a chronic and acute role for Cu. These abnormalities become apparent when the CDs rats are exposed to high sucrose low copper diet, triggering a vicious sequence of events: exocrine damage, recruitment of macrophages expressing IL-1beta leading to oxidative stress and even more reduction in the activity of Cu-dependent enzymes (chronic effect). When Cu levels are re-established (acute effect) they may prevent the inhibitory effect of IL-1beta on insulin release and may restore the activity of enzymes inhibited by IL-1beta. In this study we will identify humans with marginal Cu status that may benefit from copper supplementation to normalize their GSIS. These patients will be given a daily Cu supplement (3mg/d), or placebo for a period of 6 months. GSIS, pancreatic dysfunction and biomarkers of marginal Cu status will be measured in different blood components before and every 4 weeks during treatments or placebo.
Interventions
copper sulfate 3mg/d for a period of 6 months
Sponsors
Study design
Eligibility
Inclusion criteria
* diabetic subjects with BMI \< 33 * HbA1C \< 8 * plasma copper levels of \< 90 ul/dl
Exclusion criteria
* patients with bad physical conditions
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Identify humans with marginal Cu status that may benefit from copper supplementation and normalize their GSIS. | 6 months |
Countries
Israel